Caregiver and provider perspectives on dual VA and Medicare Part D medication use in veterans with suspected dementia or cognitive impairment
Published by Oxford University Press on behalf of the American Society of Health-System Pharmacists 2021..
PURPOSE: Many older veterans with dementia fill prescriptions through both Veterans Affairs (VA) and Medicare Part D benefits. Dual VA/Part D medication use may have unintended negative consequences in terms of prescribing safety and quality. We aimed to characterize benefits and drawbacks of dual VA/Part D medication use in veterans with dementia or cognitive impairment from the perspectives of caregivers and providers.
METHODS: This was a qualitative study based on semistructured telephone interviews of 2 groups: (1) informal caregivers accompanying veterans with suspected dementia or cognitive impairment to visits at a VA Geriatric Evaluation and Management clinic (n = 11) and (2) VA healthcare providers of veterans with dementia who obtained medications via VA and Part D (n = 12). We conducted semistructured telephone interviews with caregivers and providers about benefits and drawbacks of dual VA/Part D medication use. Interview transcripts were subjected to qualitative content analysis to identify key themes.
RESULTS: Caregivers and providers both described cost and convenience benefits to dual VA/Part D medication use. Caregivers reported drawbacks including poor communication between VA and non-VA providers and difficulty managing medications from multiple systems. Providers reported potential safety risks including communication barriers, conflicting care decisions, and drug interactions.
CONCLUSION: Results of this study allow for understanding of potential policy interventions to better manage dual VA/Part D medication use for older veterans with dementia or cognitive impairment at a time when VA is expanding access to non-VA care.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:79 |
|---|---|
| Enthalten in: |
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists - 79(2022), 2 vom: 05. Jan., Seite 94-101 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schleiden, Loren J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Dementia |
|---|
| Anmerkungen: |
Date Completed 24.01.2022 Date Revised 14.10.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/ajhp/zxab343 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329962590 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329962590 | ||
| 003 | DE-627 | ||
| 005 | 20231225210249.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ajhp/zxab343 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1099.xml |
| 035 | |a (DE-627)NLM329962590 | ||
| 035 | |a (NLM)34453437 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Schleiden, Loren J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Caregiver and provider perspectives on dual VA and Medicare Part D medication use in veterans with suspected dementia or cognitive impairment |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.01.2022 | ||
| 500 | |a Date Revised 14.10.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Published by Oxford University Press on behalf of the American Society of Health-System Pharmacists 2021. | ||
| 520 | |a PURPOSE: Many older veterans with dementia fill prescriptions through both Veterans Affairs (VA) and Medicare Part D benefits. Dual VA/Part D medication use may have unintended negative consequences in terms of prescribing safety and quality. We aimed to characterize benefits and drawbacks of dual VA/Part D medication use in veterans with dementia or cognitive impairment from the perspectives of caregivers and providers | ||
| 520 | |a METHODS: This was a qualitative study based on semistructured telephone interviews of 2 groups: (1) informal caregivers accompanying veterans with suspected dementia or cognitive impairment to visits at a VA Geriatric Evaluation and Management clinic (n = 11) and (2) VA healthcare providers of veterans with dementia who obtained medications via VA and Part D (n = 12). We conducted semistructured telephone interviews with caregivers and providers about benefits and drawbacks of dual VA/Part D medication use. Interview transcripts were subjected to qualitative content analysis to identify key themes | ||
| 520 | |a RESULTS: Caregivers and providers both described cost and convenience benefits to dual VA/Part D medication use. Caregivers reported drawbacks including poor communication between VA and non-VA providers and difficulty managing medications from multiple systems. Providers reported potential safety risks including communication barriers, conflicting care decisions, and drug interactions | ||
| 520 | |a CONCLUSION: Results of this study allow for understanding of potential policy interventions to better manage dual VA/Part D medication use for older veterans with dementia or cognitive impairment at a time when VA is expanding access to non-VA care | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Medicare Part D | |
| 650 | 4 | |a dementia | |
| 650 | 4 | |a dual health system use | |
| 650 | 4 | |a qualitative research | |
| 650 | 4 | |a veterans health | |
| 700 | 1 | |a Zickmund, Susan L |e verfasserin |4 aut | |
| 700 | 1 | |a Roman, Katie Lynn |e verfasserin |4 aut | |
| 700 | 1 | |a Kennedy, Kayla |e verfasserin |4 aut | |
| 700 | 1 | |a Thorpe, Joshua M |e verfasserin |4 aut | |
| 700 | 1 | |a Rossi, Michelle I |e verfasserin |4 aut | |
| 700 | 1 | |a Niznik, Joshua D |e verfasserin |4 aut | |
| 700 | 1 | |a Springer, Sydney P |e verfasserin |4 aut | |
| 700 | 1 | |a Thorpe, Carolyn T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists |d 1995 |g 79(2022), 2 vom: 05. Jan., Seite 94-101 |w (DE-627)NLM075145952 |x 1535-2900 |7 nnns |
| 773 | 1 | 8 | |g volume:79 |g year:2022 |g number:2 |g day:05 |g month:01 |g pages:94-101 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ajhp/zxab343 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 79 |j 2022 |e 2 |b 05 |c 01 |h 94-101 | ||